Adith Arun
Adith ArunWriting about medicine, biology, stats, and anything in between. Commentary on new medical research, clinical trials, and biotech companies.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 18 | Subscribers | Read | aditharun.com |
Curious about how many subscribers Adith Arun has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Interpreting FDA's plausible mechanism pathway draft guidance document
FDA introduced the plausible mechanism pathway a few months ago (NEJM piece). Makary (FDA commissioner) and Prasad (FDA CBER head) wrote the following:
On halting the progression of frontotemporal dementia
What would a reasonable bar for success look like given that we have no disease modifying therapies available to treat frontotemporal dementia due to a pathogenic progranulin mutation (FTD-GRN)? After a one-time minimally-invasive treatment...
Clascoterone is not a cure for baldness
Cosmo Pharmaceuticals (OTCMKTS: CMOPF) recently released a press release from their two phase 3 studies of clascoterone in male pattern hair loss. Here is the clipping and the full link can be found here.
Semaglutide in early-stage Alzheimer's Disease
Novo Nordisk is presenting top line results from their EVOKE and EVOKE+ trials at CTAD on December 3 at 5:05 pm PST. EVOKE and EVOKE+ are two trials evaluating oral once-daily semaglutide against placebo in early symptomatic Alzheimer’s Dis...
Authors
The writers behind this newsletter.
Writing at the intersection of medicine and statistics
Frequently Asked Questions
How can I access the email archive for Adith Arun?
You can find recent issues that have been published by Adith Arun on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Adith Arun have?
To see how many people subscribe to Adith Arun, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Adith Arun?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Adith Arun as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Adith Arun?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Adith Arun using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Adith Arun?
Scroll up to where it says Similar Newsletters to see other publications like Adith Arun. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Adith Arun?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.